263 related articles for article (PubMed ID: 487813)
1. Subdermal norethindrone pellets -- a method for contraception?
Odlind V; Moo-Young AJ; Gupta GN; Weiner E; Johansson ED
Contraception; 1979 Jun; 19(6):639-48. PubMed ID: 487813
[TBL] [Abstract][Full Text] [Related]
2. A regimen of oral contraceptives restricted to the periovulatory period may permit folliculogenesis but inhibit ovulation.
Letterie GS
Contraception; 1998 Jan; 57(1):39-44. PubMed ID: 9554249
[TBL] [Abstract][Full Text] [Related]
3. Phase I comparative clinical trial with subdermal implants--bioabsorbable levonorgestrel or norethisterone pellet fused with cholesterol.
Joshi UM; Joshi JV; Donde UM; Sankoli GM; Virkar KD; Saxena BN
Contraception; 1985 Jan; 31(1):71-82. PubMed ID: 3921309
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneous bioabsorbable pellets of norethindrone for contraception in women: Phase I. Clinical study.
Gupta GN; Saxena BB; Landesman R; Ledger WJ
Fertil Steril; 1984 May; 41(5):726-31. PubMed ID: 6714449
[TBL] [Abstract][Full Text] [Related]
5. Effects of different doses of norethisterone on ovarian function, serum sex hormone binding globulin and high density lipoprotein-cholesterol.
Song S; Chen JK; Lu CH; Yang PJ; Yang QY; Fan BC; He ML; Gui YL; Li LM; Fotherby K
Contraception; 1993 Jun; 47(6):527-37. PubMed ID: 8334889
[TBL] [Abstract][Full Text] [Related]
6. Contraceptive efficacy, pharmacokinetics, and safety of Annuelle biodegradable norethindrone pellet implants.
Raymond EG; Singh M; Archer DF; Saxena BB; Baker J; Cole D
Fertil Steril; 1996 Dec; 66(6):954-61. PubMed ID: 8941061
[TBL] [Abstract][Full Text] [Related]
7. Release of 19-nor-testosterone type of contraceptive steroids through different drug delivery systems into serum and breast milk of lactating women.
Toddywalla VS; Mehta S; Virkar KD; Saxena BN
Contraception; 1980 Mar; 21(3):217-23. PubMed ID: 7389350
[TBL] [Abstract][Full Text] [Related]
8. Biodegradable norethindrone (NET:cholesterol) contraceptive implants: phase II-A: a clinical study in women.
Singh M; Saxena BB; Raghubanshi RS; Ledger WJ; Harman SM; Leonard RJ
Contraception; 1997 Jan; 55(1):23-33. PubMed ID: 9013058
[TBL] [Abstract][Full Text] [Related]
9. Serum norethindrone (NET) concentrations following intramuscular NET enanthate injection. Effect upon serum LH, FSH, estradiol and progesterone.
Goebelsmann U; Stanczyk FZ; Brenner PF; Goebelsmann AE; Gentzschein EK; Mishell DR
Contraception; 1979 Mar; 19(3):283-313. PubMed ID: 572279
[TBL] [Abstract][Full Text] [Related]
10. The effect of injectable norethisterone oenanthate on ovarian hormones in Thai women.
Werawatgoompa S; Vaivanijkul B; Leepipatpaiboon S; Channiyom K; Virutamasen P; Dusitsin N
Contraception; 1980 Mar; 21(3):299-309. PubMed ID: 7389353
[TBL] [Abstract][Full Text] [Related]
11. Effects of low dose oral contraceptives containing norethindrome and ethinyl estradiol on serum levels of progesterone and pituitary gonadotropins.
McGuire JL; Bariso CD; Yuliano E; Hume RJ; Pasquale SA
Contraception; 1975 Mar; 11(3):329-38. PubMed ID: 1116369
[TBL] [Abstract][Full Text] [Related]
12. Ovulation inhibition following vaginal administration of pills containing norethindrone and mestranol.
Coutinho EM; Silva AR; Carreira C; Barbosa I
Contraception; 1984 Feb; 29(2):197-202. PubMed ID: 6723313
[TBL] [Abstract][Full Text] [Related]
13. The contraceptive efficacy of 10mg or 25mg of norethindrone given orally on day 15-22 of the human menstrual cycle.
Nygren KG; Johansson ED; Wide L
Contraception; 1974 Mar; 9(3):249-56. PubMed ID: 4442274
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamics of a contraceptive vaginal ring releasing norethindrone and estradiol: ovarian function, bleeding control and lipoprotein patterns.
Victor A; Lithell H; Selinus I; Vessby B
Ups J Med Sci; 1984; 89(2):179-88. PubMed ID: 6380076
[TBL] [Abstract][Full Text] [Related]
15. Postovulatory contraception in women with large doses of norethindrone.
Nygren KG; Johansson ED; Wide L
Contraception; 1972 Jun; 5(6):445-56. PubMed ID: 4650660
[TBL] [Abstract][Full Text] [Related]
16. Norethisterone contraceptive microspheres.
Rivera R; Alvarado G; Flores C; Aldaba S; Hernandez A
J Steroid Biochem; 1987; 27(4-6):1003-7. PubMed ID: 3695501
[TBL] [Abstract][Full Text] [Related]
17. Effect of norethindrone acetate released from a single silastic implant on serum FSH, LH, progesterone and estradiol-17beta of women during first eight months of treatment.
Rahman SA; Jha P; Laumas V; Jain AK; Dileepkumar ; Takkar D; Hingorani V; Laumas KR
Contraception; 1977 Nov; 16(5):487-97. PubMed ID: 590011
[TBL] [Abstract][Full Text] [Related]
18. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
[TBL] [Abstract][Full Text] [Related]
19. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
[TBL] [Abstract][Full Text] [Related]
20. Long-acting hormonal contraceptives for women.
Garza-Flores J; Hall PE; Perez-Palacios G
J Steroid Biochem Mol Biol; 1991; 40(4-6):697-704. PubMed ID: 1958567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]